Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population

Archives of Dermatological Research

Volumn 303, Issue 9, 2011, Pages 679-684

  Kim, Su Kang ^a   Hong, Mi Sook ^a   Shin, Min Kyung ^a   Uhm, Yoon Kyung ^a   Chung, Joo Ho ^a   Lee, Mu Hyoung ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Major histocompatibility complex, class I MHC; Non classical MHC; Non segmental vitiligo; Single nucleotide polymorphism

Indexed keywords

HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KOREAN; MAJOR CLINICAL STUDY; MALE; NON SEGMENTAL VITILIGO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

ADULT; AGE OF ONSET; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-G ANTIGENS; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VITILIGO;

EID: 80755129046     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1160-x     Document Type: Article

References (20)

1. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
2. Consortium 1999 Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium Nature 401 921 923 10.1038/44853 (Pubitemid 29518961)
3. R Etzensperger RM McMahon EY Jones L Fugger 2008 Dissection of the multiple sclerosis associated DR2 haplotype J Autoimmun 31 201 207 18513924 10.1016/j.jaut.2008.04.016 1:CAS:528:DC%2BD1cXhsVWrs7zN
4. RM Halder JL Chappell 2009 Vitiligo update Semin Cutan Med Surg 28 86 92 19608058 10.1016/j.sder.2009.04.008 1:CAS:528:DC%2BC3cXhtlWlsL3K
5. EM Jacobson A Huber Y Tomer 2008 The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology J Autoimmun 30 58 62 18178059 10.1016/j.jaut.2007.11.010 1:CAS:528:DC%2BD1cXlvFSjug%3D%3D
6. Y Jin SA Birlea PR Fain, et al. 2010 Common variants in FOXP1 are associated with generalized vitiligo Nat Genet 42 576 578 20526340 10.1038/ng.602 1:CAS:528:DC%2BC3cXntVSrt74%3D
7. KH Jung JY Ban HJ Kim, et al. 2008 Genetic association study of THRB polymorphisms with obesity in Korean population Mol cell Toxicol 4 124 131
8. S Kovats EK Main C Librach M Stubblebine SJ Fisher R DeMars 1990 A class I antigen, HLA-G, expressed in human trophoblasts Science 248 220 223 2326636 10.1126/science.2326636 1:CAS:528:DyaK3cXktVChuro%3D (Pubitemid 120031455)
9. J McCluskey CA Peh 1999 The human leucocyte antigens and clinical medicine: an overview Rev Immunogenet 1 3 20 11256570 1:CAS:528: DyaK1MXntVWju7g%3D
10. MT McMaster CL Librach Y Zhou, et al. 1995 Human placental HLA-G expression is restricted to differentiated cytotrophoblasts J Immunol 154 3771 3778 7706718 1:CAS:528:DyaK2MXkvFOrt7g%3D
11. J Moscoso JI Serrano-Vela R Pacheco A Arnaiz-Villena 2006 HLA-G, -E and -F: allelism, function and evolution Transpl Immunol 17 61 64 17157219 10.1016/j.trim.2006.09.010 1:CAS:528:DC%2BD28Xht12rtr%2FJ (Pubitemid 44828794)
12. C Quan YQ Ren LH Xiang, et al. 2010 Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC Nat Genet 42 614 618 20526339 10.1038/ng.603 1:CAS:528:DC%2BC3cXntVSrurs%3D
13. B Riteau N Rouas-Freiss C Menier P Paul J Dausset ED Carosella 2001 HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis J Immunol 166 5018 5026 11290782 1:CAS:528:DC%2BD3MXivVKms74%3D (Pubitemid 32280714)
14. N Rouas-Freiss RM Goncalves C Menier J Dausset ED Carosella 1997 Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis Proc Natl Acad Sci USA 94 11520 11525 9326642 10.1073/pnas.94.21.11520 1:CAS:528:DyaK2sXmslaqsrk%3D (Pubitemid 27451031)
15. N Rouas-Freiss RE Marchal M Kirszenbaum J Dausset ED Carosella 1997 The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94 5249 5254 9144223 10.1073/pnas.94.10.5249 1:CAS:528:DyaK2sXjtlensrY%3D (Pubitemid 27214769)
16. X Sole E Guino J Valls R Iniesta V Moreno 2006 SNPStats: a web tool for the analysis of association studies Bioinformatics 22 1928 1929 16720584 10.1093/bioinformatics/btl268 1:CAS:528:DC%2BD28Xotl2qsLo%3D (Pubitemid 44283043)
17. RA Spritz 2008 The genetics of generalized vitiligo Curr Dir Autoimmun 10 244 257 18460890 10.1159/000131501 1:CAS:528:DC%2BD1MXltFeht74%3D
18. TD Veit EA Cordero T Mucenic, et al. 2009 Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus Lupus 18 424 430 19318395 10.1177/0961203308098187 1:CAS:528:DC%2BD1MXlvFKqu7s%3D
19. TD Veit P Vianna I Scheibel, et al. 2008 Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis Tissue Antigens 71 440 446 18331529 10.1111/j.1399-0039. 2008.01019.x 1:CAS:528:DC%2BD1cXmt1CksrY%3D (Pubitemid 351537544)
20. IA York KL Rock 1996 Antigen processing and presentation by the class I major histocompatibility complex Annu Rev Immunol 14 369 396 8717519 10.1146/annurev.immunol.14.1.369 1:CAS:528:DyaK28XitlCgtLc%3D (Pubitemid 26130189)